Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0000921895-26-000788

Options or other derivatives

  • Director sold 896,800 shares

From the SEC's structured data for this filing

Trades in this filing

Lazar David E. · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-23 Sale : show line 1 in the form Series AA Convertible Non-Redeemable Preferred Stock −196,800 103,200 D
2026-03-23 Sale : show line 2 in the form Series AAA Convertible Non-Redeemable Preferred Stock −700,000 0 D
Loading xslF345X06/form412227indp_03232026.xml…